biosimilars

Optum axes Humira from some of its preferred formularies: report

UnitedHealth Group's Optum Rx will join its peers in the big three pharmacy benefit managers by pulling Humira from some of its preferred formularies.

Paige Minemyer Sep 10, 2024 4:00pm

drug prices biologics drug costs IRA money cash payment co-pay

Accredo to make Stelara biosimilar available at $0 out-of-pocket

Sep 5, 2024 6:00am

Woman paying for a prescription at a pharmacy

Boehringer, GoodRx team to boost access to Humira biosimilars

Jul 18, 2024 3:00pm

AHIP 2024: The hurdles to widespread biosimilar adoption

Jun 12, 2024 5:30am

Evernorth's Accredo to offer Humira biosim at $0 out-of-pocket

Apr 25, 2024 4:30pm

Industry shook by CMS final rule on broker comp, health equity

Apr 5, 2024 1:02pm